This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Carrillo, A. J.
Right arrow Articles by Guarro, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Carrillo, A. J.
Right arrow Articles by Guarro, J.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, July 2001, p. 2151-2153, Vol. 45, No. 7
0066-4804/01/$04.00+0   DOI: 10.1128/AAC.45.7.2151-2153.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

In Vitro Activities of Four Novel Triazoles against Scedosporium spp.

A. J. Carrillo1 and J. Guarro2,*

Department of Microbiology, Asesoría Científica y de Investigación Aplicada, 08037 Barcelona,1 and Unitat de Microbiologia, Facultat de Medicina, and Institut d'Estudis Avançats, Universitat Rovira i Virgili, 43201 Reus,2 Spain

Received 30 January 2001/Returned for modification 22 February 2001/Accepted 9 April 2001

In order to develop new approaches to the treatment of the severe and usually fatal infections caused by Scedosporium spp., the in vitro antifungal activities of four novel triazoles (posaconazole, ravuconazole, voriconazole, and UR-9825) and some current antifungals (amphotericin B, ketoconazole, itraconazole, and nystatin) were determined. The latter group was clearly ineffective against the two species tested. The four new antifungals showed activity against Scedosporium apiospermum, and UR-9825 and voriconazole were active against S. prolificans.

* Corresponding author. Mailing address: Unitat de Microbiologia, Facultat de Medicina, Universitat Rovira i Virgili, C/St. Llorenç, 21, 43201 Reus, Spain. Phone: (34) 977-759359. Fax: (34) 977-759322. E-mail: umb{at}fmcs.urv.es.

Antimicrobial Agents and Chemotherapy, July 2001, p. 2151-2153, Vol. 45, No. 7
0066-4804/01/$04.00+0   DOI: 10.1128/AAC.45.7.2151-2153.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Karlsson, M. O., Lutsar, I., Milligan, P. A. (2009). Population Pharmacokinetic Analysis of Voriconazole Plasma Concentration Data from Pediatric Studies. Antimicrob. Agents Chemother. 53: 935-944 [Abstract] [Full Text]  
  • Cortez, K. J., Roilides, E., Quiroz-Telles, F., Meletiadis, J., Antachopoulos, C., Knudsen, T., Buchanan, W., Milanovich, J., Sutton, D. A., Fothergill, A., Rinaldi, M. G., Shea, Y. R., Zaoutis, T., Kottilil, S., Walsh, T. J. (2008). Infections Caused by Scedosporium spp.. Clin. Microbiol. Rev. 21: 157-197 [Abstract] [Full Text]  
  • Goodwin, M. L., Drew, R. H. (2008). Antifungal serum concentration monitoring: an update. J Antimicrob Chemother 61: 17-25 [Abstract] [Full Text]  
  • Caira, M., Girmenia, C., Valentini, C. G., Sanguinetti, M., Bonini, A., Rossi, G., Fianchi, L., Leone, G., Pagano, L. (2008). Scedosporiosis in patients with acute leukemia: a retrospective multicenter report. haematol 93: 104-110 [Abstract] [Full Text]  
  • Gilgado, F., Serena, C., Cano, J., Gene, J., Guarro, J. (2006). Antifungal Susceptibilities of the Species of the Pseudallescheria boydii Complex. Antimicrob. Agents Chemother. 50: 4211-4213 [Abstract] [Full Text]  
  • Enoch, D. A., Ludlam, H. A., Brown, N. M. (2006). Invasive fungal infections: a review of epidemiology and management options.. J Med Microbiol 55: 809-818 [Abstract] [Full Text]  
  • Sabatelli, F., Patel, R., Mann, P. A., Mendrick, C. A., Norris, C. C., Hare, R., Loebenberg, D., Black, T. A., McNicholas, P. M. (2006). In Vitro Activities of Posaconazole, Fluconazole, Itraconazole, Voriconazole, and Amphotericin B against a Large Collection of Clinically Important Molds and Yeasts.. Antimicrob. Agents Chemother. 50: 2009-2015 [Abstract] [Full Text]  
  • Cuenca-Estrella, M., Gomez-Lopez, A., Mellado, E., Garcia-Effron, G., Monzon, A., Rodriguez-Tudela, J. L. (2005). In Vitro Activity of Ravuconazole against 923 Clinical Isolates of Nondermatophyte Filamentous Fungi. Antimicrob. Agents Chemother. 49: 5136-5138 [Abstract] [Full Text]  
  • Gilgado, F., Cano, J., Gene, J., Guarro, J. (2005). Molecular Phylogeny of the Pseudallescheria boydii Species Complex: Proposal of Two New Species. J. Clin. Microbiol. 43: 4930-4942 [Abstract] [Full Text]  
  • Pitisuttithum, P., Negroni, R., Graybill, J. R., Bustamante, B., Pappas, P., Chapman, S., Hare, R. S., Hardalo, C. J. (2005). Activity of posaconazole in the treatment of central nervous system fungal infections. J Antimicrob Chemother 56: 745-755 [Abstract] [Full Text]  
  • Carrillo-Munoz, A.-J., Quindos, G., Ruesga, M., Alonso, R., del Valle, O., Hernandez-Molina, J. M., McNicholas, P., Loebenberg, D., Santos, P. (2005). Antifungal activity of posaconazole compared with fluconazole and amphotericin B against yeasts from oropharyngeal candidiasis and other infections. J Antimicrob Chemother 55: 317-319 [Abstract] [Full Text]  
  • Capilla, J., Mayayo, E., Serena, C., Pastor, F. J., Guarro, J. (2004). A novel murine model of cerebral scedosporiosis: lack of efficacy of amphotericin B. J Antimicrob Chemother 54: 1092-1095 [Abstract] [Full Text]  
  • Simitsopoulou, M., Gil-Lamaignere, C., Avramidis, N., Maloukou, A., Lekkas, S., Havlova, E., Kourounaki, L., Loebenberg, D., Roilides, E. (2004). Antifungal Activities of Posaconazole and Granulocyte-Macrophage Colony-Stimulating Factor Ex Vivo and in Mice with Disseminated Infection Due to Scedosporium prolificans. Antimicrob. Agents Chemother. 48: 3801-3805 [Abstract] [Full Text]  
  • Capilla, J., Guarro, J. (2004). Correlation between In Vitro Susceptibility of Scedosporium apiospermum to Voriconazole and In Vivo Outcome of Scedosporiosis in Guinea Pigs. Antimicrob. Agents Chemother. 48: 4009-4011 [Abstract] [Full Text]  
  • Krieter, P., Flannery, B., Musick, T., Gohdes, M., Martinho, M., Courtney, R. (2004). Disposition of Posaconazole following Single-Dose Oral Administration in Healthy Subjects. Antimicrob. Agents Chemother. 48: 3543-3551 [Abstract] [Full Text]  
  • Cuenca-Estrella, M., Gomez-Lopez, A., Mellado, E., Garcia-Effron, G., Rodriguez-Tudela, J. L. (2004). In Vitro Activities of Ravuconazole and Four Other Antifungal Agents against Fluconazole-Resistant or -Susceptible Clinical Yeast Isolates. Antimicrob. Agents Chemother. 48: 3107-3111 [Abstract] [Full Text]  
  • Petraitiene, R., Petraitis, V., Lyman, C. A., Groll, A. H., Mickiene, D., Peter, J., Bacher, J., Roussillon, K., Hemmings, M., Armstrong, D., Avila, N. A., Walsh, T. J. (2004). Efficacy, Safety, and Plasma Pharmacokinetics of Escalating Dosages of Intravenously Administered Ravuconazole Lysine Phosphoester for Treatment of Experimental Pulmonary Aspergillosis in Persistently Neutropenic Rabbits. Antimicrob. Agents Chemother. 48: 1188-1196 [Abstract] [Full Text]  
  • Courtney, R., Radwanski, E., Lim, J., Laughlin, M. (2004). Pharmacokinetics of Posaconazole Coadministered with Antacid in Fasting or Nonfasting Healthy Men. Antimicrob. Agents Chemother. 48: 804-808 [Abstract] [Full Text]  
  • Capilla, J., Serena, C., Pastor, F. J., Ortoneda, M., Guarro, J. (2003). Efficacy of Voriconazole in Treatment of Systemic Scedosporiosis in Neutropenic Mice. Antimicrob. Agents Chemother. 47: 3976-3978 [Abstract] [Full Text]  
  • Gil-Lamaignere, C., Roilides, E., Lyman, C. A., Simitsopoulou, M., Stergiopoulou, T., Maloukou, A., Walsh, T. J. (2003). Human Phagocytic Cell Responses to Scedosporium apiospermum (Pseudallescheria boydii): Variable Susceptibility to Oxidative Injury. Infect. Immun. 71: 6472-6478 [Abstract] [Full Text]  
  • Courtney, R., Pai, S., Laughlin, M., Lim, J., Batra, V. (2003). Pharmacokinetics, Safety, and Tolerability of Oral Posaconazole Administered in Single and Multiple Doses in Healthy Adults. Antimicrob. Agents Chemother. 47: 2788-2795 [Abstract] [Full Text]  
  • Steinbach, W. J., Schell, W. A., Miller, J. L., Perfect, J. R. (2003). Scedosporium prolificans Osteomyelitis in an Immunocompetent Child Treated with Voriconazole and Caspofungin, as Well as Locally Applied Polyhexamethylene Biguanide. J. Clin. Microbiol. 41: 3981-3985 [Abstract] [Full Text]  
  • Garau, M., Pereiro, M. Jr., del Palacio, A. (2003). In Vitro Susceptibilities of Malassezia Species to a New Triazole, Albaconazole (UR-9825), and Other Antifungal Compounds. Antimicrob. Agents Chemother. 47: 2342-2344 [Abstract] [Full Text]  
  • Meletiadis, J., Mouton, J. W., Meis, J. F. G. M., Verweij, P. E. (2003). In Vitro Drug Interaction Modeling of Combinations of Azoles with Terbinafine against Clinical Scedosporium prolificans Isolates. Antimicrob. Agents Chemother. 47: 106-117 [Abstract] [Full Text]  
  • ORTONEDA, M., PASTOR, F.J., MAYAYO, E., GUARRO, J. (2002). Comparison of the virulence of Scedosporium prolificans strains from different origins in a murine model. J Med Microbiol 51: 924-928 [Abstract] [Full Text]  
  • Afeltra, J., Dannaoui, E., Meis, J. F. G. M., Rodriguez-Tudela, J. L., Verweij, P. E. (2002). In Vitro Synergistic Interaction between Amphotericin B and Pentamidine against Scedosporium prolificans. Antimicrob. Agents Chemother. 46: 3323-3326 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»